BioNTech Plunges as Drugmaker Swings to a Loss. More Than Earnings Are Weighing on the Stock.Barrons • 03/10/26
BioNTech Announces Fourth Quarter and Full Year 2025 Financial Results and Corporate UpdateGlobeNewsWire • 03/10/26
BioNTech and Co-Founders Announce Plan to Pursue Next-Generation mRNA Innovations in Co-Founders-Led New Company as BioNTech Advances Toward Becoming a Multi-Product Company by 2030GlobeNewsWire • 03/10/26
BioNTech to Report Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on March 10, 2026GlobeNewsWire • 02/24/26
BioNTech Announces Appointment of Kylie Jimenez to Management Board as Chief People OfficerGlobeNewsWire • 01/28/26
BioNTech (BNTX) Soars 11.8%: Is Further Upside Left in the Stock?Zacks Investment Research • 01/22/26
BioNTech SE (BNTX) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/14/26
BioNTech Provides Strategic Business Update and Outlines 2026 Areas of Focus at 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/12/26
University of Pennsylvania, BioNTech, and OUP Launch $50 Million Life Sciences FundBusiness Wire • 01/09/26
BioNTech Closes Acquisition of CureVac N.V. Including Subsequent Offering Period to Strengthen its Unique Position in the mRNA FieldGlobeNewsWire • 12/18/25
BioNTech: Maintaining "Strong Buy" After Part 1 Success Of Next-Gen Anti-CTLA-4 GotistobartSeeking Alpha • 12/09/25
BioNTech and Bristol Myers Squibb Present First Global Phase 2 Data for PD-L1xVEGF-A Bispecific Antibody Pumitamig Showing Encouraging Efficacy in Advanced Triple-Negative Breast CancerGlobeNewsWire • 12/09/25
BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung CancerGlobeNewsWire • 12/06/25
Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young menMarket Watch • 12/01/25
Moderna, BioNTech Slammed After FDA Links Covid Shots To 10 DeathsInvestors Business Daily • 12/01/25
BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time ExpirationGlobeNewsWire • 11/26/25
BioNTech SE (BNTX) Discusses Oncology Innovation Strategy, Combination Therapies and Personalized Cancer Immunotherapies TranscriptSeeking Alpha • 11/17/25